Render Target: STATIC
Render Timestamp: 2024-12-26T11:18:03.744Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-10-31 20:01:07.098
Product last modified at: 2024-12-10T17:45:08.092Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77

Mouse Fc Receptor Blocking Solution (CD16/CD32) Rat mAb #88280

    Supporting Data

    REACTIVITY
    SENSITIVITY Endogenous
    MW (kDa)
    Source/Isotype Rat IgG2b

    Product Information

    Product Usage Information

    To block the interaction of IgG with mouse Fc receptors, add 1.0 μg of antibody per million cells in 100 µl of buffer. Incubate 10 mins at 4ºC or room temperature as desired. A wash step is not needed prior to adding antibodies of interest. The optimal blocking concentration may be assay dependent and may require titration.

    Storage

    Supplied in 10 mM NaH2PO4, 150 mM NaCl, 0.09% NaN3, pH7.2. This product is stable for 12 months when stored at 4ºC. Do not aliquot the antibody. Do not freeze.

    Specificity / Sensitivity

    Mouse Fc Receptor Blocking Solution (CD16/CD32) Rat mAb binds to all isoforms of mouse CD16 and CD32, preventing interaction with the IgG Fc domain.

    Source / Purification

    This monoclonal antibody was purified from tissue culture supernatant via affinity chromatography.

    Background

    The 2.4G2 clone is widely used as a blocking reagent to prevent interactions between mouse Fc receptors and IgG. By binding to CD32 (FcgammaRII) and CD16 (FcgammaRIII), the 2.4G2 clone prevents the Fc receptor proteins from being able to interact with the Fc domain of antibodies subsequently added for analysis. Performing an Fc blocking step thus reduces background and false positive events in flow cytometry assays on live cells.
      For Research Use Only. Not For Use In Diagnostic Procedures.
      Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
      All other trademarks are the property of their respective owners. Visit our Trademark Information page.